Skip to content

Clinical trials

Completed Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Status: Completed Country / region: Japan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20061
20074
20081
20092
20112
20122
20133
20141
20172
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Pfizer4
Bristol-Myers Squibb3
Kanto CML Study Group2
Ariad Pharmaceuticals1
Keio University1
Otsuka Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive22
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Bone Marrow Diseases3
Leukemia3
Hematologic Diseases2
Hematologic Neoplasms2
Leukemia, Myeloid2
Leukemia, Myeloid, Acute2
Myeloproliferative Disorders2
Bronchiolitis Obliterans Syndrome1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.